Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
general
Chemotherapy of Theileria parva infection
Nature, Volume 261, No. 5562, Year 1976
Notification
URL copied to clipboard!
Description
EAST coast fever (ECF), the most important tick-borne disease of cattle in eastern and central Africa, is caused by the protozoan parasite Theileria parva. No successful therapy is available and mortality can reach 96% (ref. 1), although large doses of tetracyclines have some prophylactic effect2. The search for an active drug has been hindered by the lack of a laboratory model of the infection. An in vitro screening process has been established, using the infected bovine lymphoid cell culture methods developed by Malmquist et al.3. This has now shown that 2-hydroxy-3-(8-cyclohexyloctyl)-1,4- naphthoquinone (Menoctone, Sterling-Winthrop) has a high level of anti-theileria activity in vitro. Subsequent tests in cattle artificially infected with ECF confirmed the activity of this compound against the disease. © 1976 Nature Publishing Group.
Authors & Co-Authors
McHardy, Nicholas
United Kingdom, London
Wellcome Research Laboratories, London
Haigh, A. J.B.
Unknown Affiliation
Dolan, Thomas T.
Kenya, Nairobi
Ministry of Overseas Development, Kenya
Statistics
Citations: 71
Authors: 3
Affiliations: 2
Identifiers
Doi:
10.1038/261698a0
ISSN:
00280836
Research Areas
Cancer